- Home
- ENGN vs MLAB Comparison
ENGN vs MLAB Comparison
Compare ENGN & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENGN
- MLAB
- Stock Information
- Founded
- ENGN 1999
- MLAB 1982
- Country
- ENGN Canada
- MLAB United States
- Employees
- ENGN N/A
- MLAB N/A
- Industry
- ENGN
- MLAB Industrial Machinery/Components
- Sector
- ENGN
- MLAB Industrials
- Exchange
- ENGN Nasdaq
- MLAB Nasdaq
- Market Cap
- ENGN 321.5M
- MLAB 341.1M
- IPO Year
- ENGN N/A
- MLAB N/A
- Fundamental
- Price
- ENGN $5.97
- MLAB $66.29
- Analyst Decision
- ENGN Buy
- MLAB Buy
- Analyst Count
- ENGN 8
- MLAB 2
- Target Price
- ENGN $21.50
- MLAB $113.50
- AVG Volume (30 Days)
- ENGN 217.5K
- MLAB 112.4K
- Earning Date
- ENGN 09-11-2025
- MLAB 11-06-2025
- Dividend Yield
- ENGN N/A
- MLAB 0.95%
- EPS Growth
- ENGN N/A
- MLAB N/A
- EPS
- ENGN N/A
- MLAB N/A
- Revenue
- ENGN N/A
- MLAB $242,351,000.00
- Revenue This Year
- ENGN N/A
- MLAB $5.38
- Revenue Next Year
- ENGN N/A
- MLAB $5.25
- P/E Ratio
- ENGN N/A
- MLAB N/A
- Revenue Growth
- ENGN N/A
- MLAB 8.33
- 52 Week Low
- ENGN $2.65
- MLAB $55.45
- 52 Week High
- ENGN $11.00
- MLAB $155.12
- Technical
- Relative Strength Index (RSI)
- ENGN 72.82
- MLAB 48.83
- Support Level
- ENGN $5.52
- MLAB $58.83
- Resistance Level
- ENGN $6.54
- MLAB $64.35
- Average True Range (ATR)
- ENGN 0.53
- MLAB 3.64
- MACD
- ENGN 0.12
- MLAB 0.31
- Stochastic Oscillator
- ENGN 76.64
- MLAB 52.87
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.
About MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.